Acute Traumatic Subdural Hematoma and Anticoagulation Risk
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2023-03 · 50 (2) · 188-193
DOI: 10.1017/cjn.2021.518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 03.01.2022. Verfasst von Maryam Kia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Hematoma, Subdural, Hematoma, Subdural, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Anticoagulation is used to prevent thromboembolic events. It is a common practice to hold anticoagulation in the first few days following a traumatic brain injury (TBI) with intracranial hemorrhage. However, traumatic subdural hematomas (SDH) are prone to re-hemorrhage long after the trauma. Data are scarce in the literature on the best timing to resume anticoagulation following a TBI.
Methods
Review of 95 consecutive patients admitted to a level 1 trauma center with a diagnosis of traumatic SDH and requiring anticoagulation. The reasons for anticoagulation, the amount of time without anticoagulation, CT characteristics, and the incidence of thromboembolic events or SDH re-hemorrhage were collected.
Results
41.3% used anticoagulation for coronary artery disease and peripheral vascular disease, 24% for atrial fibrillation, 12% for cardiac valve replacement, and 12% for venous thromboembolic events. Anticoagulation was held a median of 67 days. For most patients (82.1%), anticoagulation was re-introduced once the SDH had completely resolved. For 17.9%, anticoagulation was restarted while the SDH had not completely resolved. One (1.1%) patient suffered from an atrial clot while anticoagulation was held. For those with residual SDH, 41.2% suffered from a SDH re-hemorrhage and 17.6% required surgery. The risk of re-hemorrhage climbed to 62.5% if the SDH remnant was large.
Conclusion
Anticoagulation while there is a residual SDH was associated with a significant risk of re-hemorrhage. This risk should be weighed against the risk of holding anticoagulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
- Department of Neurosurgery, McGill University Health Centre, Montreal, QC, Canada.
ORCID-Profile: Judith Marcoux
Zitieren
APA
Kia, M., Saluja, R. S., & Marcoux, J. (2023). Acute Traumatic Subdural Hematoma and Anticoagulation Risk. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 50(2), 188-193. https://doi.org/10.1017/cjn.2021.518
Vancouver
Kia M, Saluja RS, Marcoux J. Acute Traumatic Subdural Hematoma and Anticoagulation Risk. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2023;50(2):188-193. doi:10.1017/cjn.2021.518
BibTeX
@article{Kia2023,
author = {Kia, Maryam and Saluja, Rajeet Singh and Marcoux, Judith},
title = {Acute Traumatic Subdural Hematoma and Anticoagulation Risk},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2023},
volume = {50},
number = {2},
pages = {188--193},
doi = {10.1017/cjn.2021.518}
}
EUVIMED